Prime award
THE EMMES COMPANY, LLC · Department of Health and Human Services
OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC HYBRID EFFECTIVENESS/IMPLEMENTATION TRIAL (CTN-013). 09/28/2022 - 08/04/2025. DSC6. 75N95022F00003 (TO3).
Current value$1.86M
Obligated to date$0
Months remaining4
Sign in to mark this as watching, pursuing, or passed — and to be told when its end date changes.
Recompete signal
This award ends in 4 months.
Award record
| Field | Value |
|---|---|
| Recipient | THE EMMES COMPANY, LLC |
| Awarding agency | Department of Health and Human Services |
| NAICS | 541715 |
| PSC | AN11 |
| Place of performance | MD |
| Period | → Jan 31, 2027 |
| Competition | A |
| Vehicle | Standalone |
Data & sources
Record as published by USAspending.gov, vintage FY2021–FY2025 full archives · USAspending.gov, retrieved Aug 6, 2026. Values change as modifications are reported; obligations may be negative when work is de-obligated.